Lopez Ibor
Pediatric hematologist/oncologist
For Dr. Blanca López-Ibor, pediatric cancer patients must be treated from an integral point of view. This is what they do at HM CIOCC thanks to the equipment they have and the infrastructure they have. The facilities are essential to be able to carry out the care that pediatric patients require. For Dr. Blanca López-Ibor it is important that the pediatrician makes a good story and always listens to what the parents have to say. What is the survival rate for children from cancer diseases? In Spain, in neighboring countries, and in developed countries, childhood cancer survival today is around 80% of cases.
Dr. López-Ibor is an experienced specialist in Pediatric Hematology and Oncology with a degree in Medicine from the Complutense University of Madrid and a doctorate from the University of Barcelona. She is an expert in the treatment of bone and brain tumors, as well as leukemia and hematological diseases. She currently directs the Pediatric Hematology and Oncology Unit of the HM Montepríncipe Hospital, and is the author of numerous national and international scientific publications.
Location
The prestigious Dr. López-Ibor has a degree in Medicine from the Complutense University of Madrid and a doctorate from the University of Barcelona. Specialist in Pediatric Hematology and Oncology from the University of Maryland (United States), she is an expert in the treatment of bone and brain tumors, as well as in leukemia and hematological diseases.
With more than two decades of experience, he currently directs the Pediatric Hematology and Oncology Unit of the HM Montepríncipe Hospital, where children and adolescents are cared for. Previously, he held the same position at the Hospital Universitario Clínica San Rafael. In addition, she is the author of numerous national and international scientific publications.